Literature DB >> 15965428

Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria.

Whitney A High1, David Stewart, Christopher R H Wilbers, Clay J Cockerell, Mai P Hoang, James E Fitzpatrick.   

Abstract

BACKGROUND: Partial regression of primary cutaneous malignant melanoma is not uncommon and may predict a higher likelihood of metastasis and decreased survival. Complete histologic regression of a primary cutaneous melanoma is a rarer occurrence, with only 34 cases reported in the English-language or English language-summarized literature. OBSERVATION: We detail 4 cases of complete histologic regression of primary cutaneous melanoma, discovered at presentation with metastatic disease. A pigmented lesion or its remnant, coupled with historical information, was strongly suggestive of cutaneous melanoma. Histologic examination of the lesions, using multiple levels and immunohistochemical stains, failed to reveal residual melanoma. Our cases are typified by the presence of metastasis of melanoma to regional lymph nodes, with the absence of other suspect skin lesions or malignancies. In addition, we present a fifth case involving a completely regressed lesion on the scalp in a patient with cerebral melanoma metastasis and comment on the implications of this case to accepted diagnostic criteria, proposing that consideration of modification to the criteria be entertained.
CONCLUSION: The concept of completely regressed primary cutaneous melanoma is reviewed and the literature critically appraised. When one considers a diagnosis of completely regressed primary cutaneous melanoma, cases must be well documented and biopsy proven. Patients with metastatic melanoma and an occult primary lesion require a thorough skin examination, with serious consideration given to the possibility of completely regressed cutaneous melanoma.

Entities:  

Mesh:

Year:  2005        PMID: 15965428     DOI: 10.1016/j.jaad.2005.03.006

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  25 in total

Review 1.  Melanoma-associated leukoderma - immunology in black and white?

Authors:  Hadas Prag Naveh; Uma N M Rao; Lisa H Butterfield
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-09       Impact factor: 4.693

2.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

3.  Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.

Authors:  Susannah E McClain; Amber L Shada; Megan Barry; James W Patterson; Craig L Slingluff
Journal:  Melanoma Res       Date:  2012-08       Impact factor: 3.599

4.  Management decisions for nodal metastasis from an unknown primary melanoma.

Authors:  Chris C Lee; Mark B Faries; Donald L Morton
Journal:  Am J Hematol Oncol       Date:  2008-07-01

5.  The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.

Authors:  Karin Loser; Thomas Brzoska; Vinzenz Oji; Matteo Auriemma; Maik Voskort; Verena Kupas; Lars Klenner; Cornelius Mensing; Axel Hauschild; Stefan Beissert; Thomas A Luger
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

6.  Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.

Authors:  Tiefu Chen; Jie Zhu
Journal:  Med Oncol       Date:  2009-11-17       Impact factor: 3.064

7.  Fully Regressive Melanoma: A Case Without Metastasis.

Authors:  Eric Ehrsam; Joseph R Kallini; Damien Lebas; Amor Khachemoune; Philippe Modiano; Hervé Cotten
Journal:  J Clin Aesthet Dermatol       Date:  2016-08-01

8.  Gene expression signature for spontaneous cancer regression in melanoma pigs.

Authors:  Florian Rambow; Guillaume Piton; Stephan Bouet; Jean-Jaques Leplat; Sylvain Baulande; Angelique Marrau; Mark Stam; Vratislav Horak; Silvia Vincent-Naulleau
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

Review 9.  Melanocytic nevi simulant of melanoma with medicolegal relevance.

Authors:  Guido Massi
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

10.  Palliative radiation therapy for primary gastric melanoma.

Authors:  Jason M Slater; Ted C Ling; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.